Startups
At Sigmascreening, an Amsterdam based medical device company, we focus on the development of new products in the area of breast cancer screening.
The Sensitive Sigma™ Paddle is our new CE-certified patented technology which improves the detection of breast cancer with compression at optimal pressure. It optimizes compression for every single breast, thus preventing unnecessary discomfort or pain: a highly reproducible procedure with a same physical experience, year after year.
We aim to introduce new products that will improve mammography and contribute to the early detection of cancer which ultimately can saves lives.
The Sensitive Sigma™ Paddle is our new CE-certified patented technology which improves the detection of breast cancer with compression at optimal pressure. It optimizes compression for every single breast, thus preventing unnecessary discomfort or pain: a highly reproducible procedure with a same physical experience, year after year.
We aim to introduce new products that will improve mammography and contribute to the early detection of cancer which ultimately can saves lives.
Overview
Location
Netherlands, North Holland, Amsterdam
Employees
1-10
Founded date
2010
Investors 3
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Life Sciences Fund Amsterdam | lsfamsterdam.nl | |
| UvA Ventures | uvaventures.nl |
Reviews 0
FAQ about Sigmascreening
When was Sigmascreening founded?
Sigmascreening was founded in 2010.
Who has invested in Sigmascreening?
Parsers VC lists 3 investors of Sigmascreening, among them Life Sciences Fund Amsterdam and UvA Ventures.
Is Sigmascreening still active?
Yes, Sigmascreening is active; its latest activity on Parsers VC dates from Jan 14, 2022.